Arcadia Biosciences Inc. (RKDA)
NASDAQ: RKDA
· Real-Time Price · USD
4.53
0.13 (2.84%)
At close: Aug 15, 2025, 1:39 PM
Arcadia Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.78M | -7.8M | -6.39M | -6.55M | -6.79M | -13.76M | -15.46M | -15.77M | -20.39M | -15.61M | -20.84M | -20.8M | -22.43M | -16.13M | 2.03M | -2.29M | -6.77M |
Depreciation & Amortization | -102K | 113K | 314K | 556K | 606K | 449K | 313K | 314K | 388K | 479K | 602K | 816K | 951K | 1.04M | 1.1M | 1.27M | 1.1M |
Stock-Based Compensation | 452K | 512K | 539K | 546K | 643K | 717K | 782K | 934K | 1.06M | 1.11M | 1.4M | 1.44M | 1.48M | 1.54M | 1.23M | 1.36M | 1.59M |
Other Working Capital | 1.34M | 1.36M | 1.12M | -440K | -719K | -751K | 40K | 56K | -147K | 97K | -282K | 457K | 196K | -125K | 608K | 299K | 713K |
Other Non-Cash Items | -2.25M | -1.59M | -1.7M | -1M | 8.75M | 13.84M | 12.08M | 9.52M | 4.75M | -1M | -537K | 1.3M | -159K | 492K | -12.32M | -12.44M | -12.41M |
Deferred Income Tax | n/a | n/a | -1.91M | -2.7M | -13.03M | -13.03M | -11.13M | -10.33M | n/a | n/a | 2.8M | -1.17M | -2.48M | -9.89M | -12.79M | -7.64M | -1.95M |
Change in Working Capital | 977K | 379K | -1.21M | -2.33M | -3.99M | -3.51M | -93K | 1.35M | 1.63M | 1.05M | -1.7M | -4.76M | -3.41M | -2.92M | -5.21M | -4.86M | -7.23M |
Operating Cash Flow | -8.01M | -9.63M | -11.56M | -12.7M | -15.04M | -15.29M | -13.51M | -13.99M | -12.56M | -13.98M | -18.28M | -23.18M | -26.05M | -25.87M | -25.96M | -24.61M | -25.66M |
Capital Expenditures | -3K | -16K | -68K | -68K | -70K | -57K | -31K | -31K | -32K | -72K | -134K | -340K | -562K | -1.01M | -1.22M | -1.3M | -2.04M |
Cash Acquisitions | -2.01M | -1.99M | -1.91M | -1.91M | 379K | 647K | 858K | 1.14M | 908K | 1.41M | -3.12M | -3.41M | -7.71M | -7.75M | -345K | -847K | 3.4M |
Purchase of Investments | n/a | n/a | -2.52M | -2.52M | -7.53M | -7.53M | -5.57M | -5.57M | -569K | -569K | 25.15M | 25.15M | 25.15M | 50.29M | 25.15M | 25.15M | 25.15M |
Sales Maturities Of Investments | 2.52M | 2.52M | 2.5M | 2.5M | 7.5M | 7.5M | 5.57M | 5.57M | 569K | 569K | 1K | 1K | 21.85M | 21.85M | 21.84M | 22.45M | 3.05M |
Other Investing Acitivies | 9.32M | 8.84M | 8.89M | 8.72M | -4.92M | -4.91M | -4.94M | -4.89M | 163K | 920K | -19.98M | -20.04M | -24.34M | -50.27M | -26.24M | -26.74M | -20.04M |
Investing Cash Flow | 7.84M | 7.34M | 4.88M | 4.7M | -4.66M | -4.34M | -4.12M | -3.78M | 985K | 1.42M | 1.07M | 521K | 17.84M | 16.61M | 19.53M | 19.56M | 3.67M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -114K | -127K | -137K | -2.15M | -2.04M | -2.04M | 1.07M |
Common Stock Repurchased | n/a | n/a | -84.75M | -84.75M | -84.75M | -84.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 980.88M | 980.88M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -990.25M | -990.25M |
Other Financial Acitivies | 9K | 9K | -84.75M | -84.74M | -84.74M | -85.24M | 451K | -41K | 405K | 901K | -35K | 484K | 44K | -1.1M | -1.36M | 927K | 7.64M |
Financial Cash Flow | 9K | 9K | -84.75M | -84.74M | -84.74M | -79.24M | 5.52M | 10.02M | 10.02M | 4.52M | 4.41M | -89K | -93K | 21.9M | 29.75M | 32.04M | 41.86M |
Net Cash Flow | -158K | -2.28M | -6.67M | -7.98M | -19.68M | -14.13M | -12.11M | -7.75M | -1.55M | -8.04M | -12.81M | -22.74M | -8.3M | 12.64M | 23.32M | 26.98M | 19.88M |
Free Cash Flow | -8.01M | -9.64M | -11.63M | -12.76M | -15.11M | -15.35M | -13.54M | -14.02M | -12.59M | -14.05M | -18.41M | -23.52M | -26.61M | -26.88M | -27.18M | -25.91M | -27.7M |